Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity (BLOCK-ROP)
Status:
Withdrawn
Trial end date:
2018-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether a single intravitreal (into the gel of the
eye) injection of Avastin 0.625mg or 0.75mg is equivalent (non-inferior) to treatment with
standard of care laser in infants with Type I pre-threshold retinopathy of prematurity (ROP)
diagnosed at 30-36 weeks gestational age.